Fandom

VroniPlag Wiki

Iam/Fragment 003 03

< Iam

31.377Seiten in
diesem Wiki
Seite hinzufügen
Diskussion0 Teilen

Störung durch Adblocker erkannt!


Wikia ist eine gebührenfreie Seite, die sich durch Werbung finanziert. Benutzer, die Adblocker einsetzen, haben eine modifizierte Ansicht der Seite.

Wikia ist nicht verfügbar, wenn du weitere Modifikationen in dem Adblocker-Programm gemacht hast. Wenn du sie entfernst, dann wird die Seite ohne Probleme geladen.


Typus
KomplettPlagiat
Bearbeiter
Hindemith
Gesichtet
Yes.png
Untersuchte Arbeit:
Seite: 3, Zeilen: 3-12
Quelle: Hawkins and Dawson 2006
Seite(n): 1653, 1654, Zeilen: 1653: 33-43 - 1654, l.col: 1-3
Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world (626,000 diagnoses per year) and is the third most common cause of cancer-related death (598,000 deaths per year). Although HCC predominantly is a problem in developing countries, its incidence is expected to rise over the next decade in North America largely because of the increasing incidence of hepatitis C2 and the 1% to 4% risk per year of HCC developing in patients with cirrhosis (Helton et al. 2003). Unfortunately, the overall 5-year survival rate for all patients with HCC has remained steady at 3% to 5% (Parkin 2001). HCC is particularly challenging to treat because of to the common locally advanced or multifocal presentation of disease that develops in a background of cirrhosis because the survival of patients with HCC is related strongly to underlying liver function (Chevret et al. 1999).

Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C (1999) A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 31:133-141

Helton WS, Di BA, Chari R, Schwartz M, Bruix J (2003) Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 7:401-411

Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533-543

[page 1653]

Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world (626,000 diagnoses per year) and is the third most common cause of cancer-related death (598,000 deaths per year).1 Although HCC predominantly is a problem in developing countries, its incidence is expected to rise over the next decade in North America largely because of the increasing incidence of hepatitis C2 and the 1% to 4% risk per year of HCC developing in patients with cirrhosis.3 Unfortunately, the overall 5-year survival rate for all patients with HCC has remained steady at 3% to 5%.1

HCC is particularly challenging to treat because of to the common locally advanced or multifocal presentation of disease that de-

[page 1654]

velops in a background of cirrhosis. Because the survival of patients with HCC is related strongly to underlying liver function,4 [...]


1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.

2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745- 750.

3. Helton WS, Di Bisceglie A, Chari R, Schwartz M, Bruix J. Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg. 2003;7:401-411.

4. Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol. 1999;31:133-141.

Anmerkungen

The first lines of the thesis are taken verbatim from a source that is mentioned nowhere in the thesis. Also references to the literature have been taken (except one, where apparently the superscript "2" has been overlooked, such that the thesis talks now about "hepatitis C2")

Sichter
(Hindemith) Schumann

Auch bei Fandom

Zufälliges Wiki